Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00073697 · ClinicalTrials.gov registry record · Phase 4
Treatment of Depression in Adults
A Phase 4 study of Depression, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 290
- Enrollment target
- 2
- Study locations
NCT00073697 is a Phase 4 study of Depression that has completed, run by University of Pittsburgh. The registered enrollment target is 290 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (63% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT00073697, a Phase 4 study of Depression, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 290 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will determine how certain features of depressed individuals affect their responses to depression treatment.
Conditions Studied
Interventions
- DRUG Escitalopram
- BEHAVIORAL Interpersonal Psychotherapy
- OTHER Escitalopram plus IPT
Study Locations (2)
Pennsylvania
- Western Psychiatric Institute and Clinic - Depression Prevention Program - Pittsburgh
Other
- The University of Pisa - Pisa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2003-05 |
| Est. Completion | 2007-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00073697
The ClinicalTrials.gov registry entry for NCT00073697 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 290 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (63% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 3 interventions - of which Escitalopram is the first listed.
NCT00073697 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, Other.
Frequently Asked Questions
What is clinical trial NCT00073697 about?
NCT00073697 is a clinical study titled "Treatment of Depression in Adults". This study will determine how certain features of depressed individuals affect their responses to depression treatment.
What is the current status of trial NCT00073697?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 290 participants. The study started on 2003-05. Estimated completion is 2007-10.
What conditions does trial NCT00073697 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT00073697?
The interventions under investigation include: Escitalopram (DRUG), Interpersonal Psychotherapy (BEHAVIORAL), Escitalopram plus IPT (OTHER).
Who is sponsoring clinical trial NCT00073697?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00073697 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
-
Dopaminergic Therapy for Anhedonia - 2
RECRUITING · Phase 4
-
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
RECRUITING · Phase 4
-
Buspirone and Melatonin for Depression Following Traumatic Brain Injury
RECRUITING · Phase 4
-
Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression
RECRUITING · Phase 4
-
Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.